Concepts (310)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Helicobacter Infections | 62 | 2022 | 1353 | 4.340 |
Why?
|
| Helicobacter pylori | 62 | 2022 | 1436 | 4.120 |
Why?
|
| Crohn Disease | 6 | 2023 | 328 | 1.960 |
Why?
|
| Colitis, Ulcerative | 5 | 2023 | 258 | 1.590 |
Why?
|
| Inflammatory Bowel Diseases | 4 | 2023 | 346 | 1.500 |
Why?
|
| Antibodies, Bacterial | 16 | 2017 | 418 | 1.420 |
Why?
|
| Abdominal Pain | 7 | 2014 | 378 | 1.040 |
Why?
|
| Stomach Neoplasms | 5 | 2022 | 2331 | 0.890 |
Why?
|
| Prevalence | 28 | 2022 | 3404 | 0.720 |
Why?
|
| Breath Tests | 14 | 2006 | 197 | 0.720 |
Why?
|
| Cross-Sectional Studies | 20 | 2022 | 4492 | 0.610 |
Why?
|
| Asymptomatic Diseases | 1 | 2017 | 103 | 0.570 |
Why?
|
| Immunoglobulin G | 11 | 2017 | 1129 | 0.560 |
Why?
|
| Seroepidemiologic Studies | 12 | 2017 | 137 | 0.560 |
Why?
|
| Stomach Ulcer | 7 | 2007 | 108 | 0.550 |
Why?
|
| Gastroesophageal Reflux | 3 | 2008 | 368 | 0.530 |
Why?
|
| Fissure in Ano | 1 | 2015 | 8 | 0.520 |
Why?
|
| Family | 3 | 2017 | 783 | 0.490 |
Why?
|
| Gastrointestinal Diseases | 6 | 2012 | 608 | 0.470 |
Why?
|
| Gastroscopy | 5 | 2022 | 156 | 0.460 |
Why?
|
| Adolescent | 34 | 2022 | 32767 | 0.450 |
Why?
|
| Socioeconomic Factors | 18 | 2012 | 1267 | 0.440 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2014 | 81 | 0.440 |
Why?
|
| Alendronate | 4 | 2001 | 24 | 0.440 |
Why?
|
| Urea | 10 | 2002 | 304 | 0.430 |
Why?
|
| Diet | 3 | 2007 | 1477 | 0.420 |
Why?
|
| Vitamin D Deficiency | 1 | 2014 | 120 | 0.410 |
Why?
|
| Male | 65 | 2023 | 128315 | 0.400 |
Why?
|
| Child | 35 | 2022 | 30559 | 0.390 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 12 | 2017 | 1525 | 0.390 |
Why?
|
| Obesity | 3 | 2017 | 2904 | 0.390 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2017 | 444 | 0.380 |
Why?
|
| Adult | 55 | 2023 | 82040 | 0.380 |
Why?
|
| Gastritis | 8 | 2007 | 404 | 0.380 |
Why?
|
| Bone Density | 1 | 2014 | 466 | 0.370 |
Why?
|
| Peptic Ulcer | 6 | 2015 | 161 | 0.370 |
Why?
|
| Female | 63 | 2023 | 148940 | 0.360 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2014 | 565 | 0.350 |
Why?
|
| Surveys and Questionnaires | 15 | 2014 | 5923 | 0.350 |
Why?
|
| Duodenal Ulcer | 6 | 2001 | 134 | 0.340 |
Why?
|
| Risk Factors | 20 | 2018 | 17888 | 0.340 |
Why?
|
| Child, Preschool | 23 | 2017 | 17061 | 0.330 |
Why?
|
| Sex Factors | 8 | 2015 | 2184 | 0.320 |
Why?
|
| Age Distribution | 6 | 2018 | 727 | 0.310 |
Why?
|
| Humans | 86 | 2023 | 270740 | 0.310 |
Why?
|
| Bhutan | 3 | 2017 | 21 | 0.310 |
Why?
|
| Incidence | 6 | 2018 | 5824 | 0.280 |
Why?
|
| Gastric Mucosa | 7 | 2001 | 660 | 0.280 |
Why?
|
| Child Day Care Centers | 3 | 2002 | 29 | 0.280 |
Why?
|
| Middle Aged | 46 | 2018 | 90352 | 0.270 |
Why?
|
| Italy | 6 | 2015 | 191 | 0.260 |
Why?
|
| Diseases in Twins | 2 | 1998 | 110 | 0.260 |
Why?
|
| Amoxicillin | 3 | 1996 | 123 | 0.260 |
Why?
|
| Dyspepsia | 3 | 2015 | 113 | 0.260 |
Why?
|
| Life Style | 2 | 2007 | 618 | 0.260 |
Why?
|
| Host-Pathogen Interactions | 1 | 2007 | 303 | 0.250 |
Why?
|
| Aged | 35 | 2018 | 73333 | 0.240 |
Why?
|
| Hepatitis A | 2 | 2003 | 36 | 0.230 |
Why?
|
| Texas | 9 | 2018 | 6449 | 0.230 |
Why?
|
| Enzyme Inhibitors | 3 | 2007 | 1942 | 0.230 |
Why?
|
| Young Adult | 7 | 2018 | 22251 | 0.230 |
Why?
|
| Hepatitis A Virus, Human | 1 | 2003 | 9 | 0.230 |
Why?
|
| Bacterial Proteins | 4 | 2015 | 1092 | 0.220 |
Why?
|
| Bismuth | 3 | 1993 | 102 | 0.220 |
Why?
|
| Urease | 3 | 2006 | 78 | 0.210 |
Why?
|
| Vitamins | 1 | 2023 | 149 | 0.210 |
Why?
|
| Saliva | 2 | 2002 | 238 | 0.210 |
Why?
|
| Gastrointestinal Agents | 1 | 2023 | 118 | 0.210 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2007 | 440 | 0.210 |
Why?
|
| Age Factors | 12 | 2011 | 5457 | 0.200 |
Why?
|
| Vitamin D | 1 | 2023 | 260 | 0.190 |
Why?
|
| Retrospective Studies | 9 | 2023 | 39890 | 0.190 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2011 | 540 | 0.190 |
Why?
|
| Naproxen | 1 | 2001 | 25 | 0.190 |
Why?
|
| Prospective Studies | 7 | 2017 | 13414 | 0.180 |
Why?
|
| Anti-Ulcer Agents | 2 | 1999 | 127 | 0.170 |
Why?
|
| Logistic Models | 5 | 2017 | 3444 | 0.170 |
Why?
|
| Proton Pump Inhibitors | 2 | 2007 | 271 | 0.170 |
Why?
|
| Gastrostomy | 1 | 2001 | 196 | 0.170 |
Why?
|
| Omeprazole | 2 | 1996 | 110 | 0.160 |
Why?
|
| Odds Ratio | 4 | 2007 | 2311 | 0.160 |
Why?
|
| Minority Groups | 1 | 2001 | 328 | 0.160 |
Why?
|
| Salicylates | 3 | 1993 | 73 | 0.160 |
Why?
|
| Aged, 80 and over | 14 | 2017 | 30998 | 0.160 |
Why?
|
| Time Factors | 8 | 2018 | 13006 | 0.160 |
Why?
|
| Tetracycline | 3 | 1993 | 106 | 0.150 |
Why?
|
| Antigens, Bacterial | 3 | 2015 | 372 | 0.150 |
Why?
|
| Infant | 7 | 2023 | 13999 | 0.150 |
Why?
|
| Drug Therapy, Combination | 6 | 2000 | 2345 | 0.150 |
Why?
|
| Urban Health | 1 | 2018 | 84 | 0.150 |
Why?
|
| Emigration and Immigration | 1 | 2018 | 97 | 0.150 |
Why?
|
| Organometallic Compounds | 3 | 1993 | 209 | 0.140 |
Why?
|
| Bahrain | 1 | 2017 | 3 | 0.140 |
Why?
|
| Cohort Studies | 8 | 2015 | 9470 | 0.140 |
Why?
|
| Educational Status | 5 | 2007 | 392 | 0.140 |
Why?
|
| Body Mass Index | 3 | 2017 | 2232 | 0.140 |
Why?
|
| Cluster Analysis | 2 | 2017 | 1075 | 0.140 |
Why?
|
| Registries | 3 | 2018 | 2211 | 0.130 |
Why?
|
| Environmental Exposure | 1 | 1998 | 290 | 0.130 |
Why?
|
| Beverages | 1 | 1996 | 104 | 0.130 |
Why?
|
| Fasting | 2 | 2001 | 342 | 0.130 |
Why?
|
| Penicillins | 1 | 1996 | 170 | 0.130 |
Why?
|
| Emigrants and Immigrants | 1 | 2018 | 159 | 0.130 |
Why?
|
| Geographic Mapping | 1 | 2015 | 13 | 0.130 |
Why?
|
| Food Preferences | 1 | 1996 | 123 | 0.130 |
Why?
|
| Schools | 1 | 2017 | 237 | 0.130 |
Why?
|
| Sensitivity and Specificity | 7 | 2008 | 5162 | 0.130 |
Why?
|
| Carbon Isotopes | 6 | 2002 | 363 | 0.130 |
Why?
|
| Hot Temperature | 1 | 1996 | 289 | 0.130 |
Why?
|
| Recurrence | 5 | 2007 | 4878 | 0.130 |
Why?
|
| Hyperlipidemias | 1 | 2017 | 223 | 0.130 |
Why?
|
| Gastric Emptying | 2 | 2014 | 99 | 0.120 |
Why?
|
| Students | 1 | 2017 | 333 | 0.120 |
Why?
|
| Metronidazole | 4 | 2001 | 171 | 0.120 |
Why?
|
| Anti-Bacterial Agents | 5 | 2001 | 3187 | 0.110 |
Why?
|
| Social Class | 4 | 2007 | 324 | 0.110 |
Why?
|
| Dental Auxiliaries | 1 | 1992 | 2 | 0.110 |
Why?
|
| Social Environment | 1 | 1994 | 181 | 0.110 |
Why?
|
| Dentists | 1 | 1992 | 11 | 0.110 |
Why?
|
| Russia | 2 | 2007 | 55 | 0.110 |
Why?
|
| Safety-net Providers | 1 | 2013 | 55 | 0.110 |
Why?
|
| Gastroparesis | 1 | 2014 | 79 | 0.110 |
Why?
|
| Japan | 3 | 2003 | 241 | 0.110 |
Why?
|
| Malaysia | 2 | 2012 | 24 | 0.100 |
Why?
|
| Nausea | 1 | 2014 | 539 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2015 | 848 | 0.100 |
Why?
|
| Occupational Diseases | 1 | 1992 | 131 | 0.100 |
Why?
|
| Cephalosporins | 1 | 1992 | 174 | 0.100 |
Why?
|
| Chi-Square Distribution | 4 | 2011 | 1312 | 0.090 |
Why?
|
| Cross-Over Studies | 3 | 2001 | 453 | 0.090 |
Why?
|
| Chronic Disease | 1 | 2015 | 1824 | 0.090 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2015 | 625 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2015 | 1412 | 0.080 |
Why?
|
| Sweden | 2 | 2000 | 87 | 0.080 |
Why?
|
| Serologic Tests | 2 | 2003 | 147 | 0.080 |
Why?
|
| Radiation Dosage | 1 | 2013 | 1042 | 0.080 |
Why?
|
| Sex Distribution | 2 | 2002 | 497 | 0.080 |
Why?
|
| Carbon Dioxide | 3 | 1999 | 328 | 0.080 |
Why?
|
| Diabetes Mellitus | 1 | 2017 | 1024 | 0.080 |
Why?
|
| Reproducibility of Results | 4 | 2008 | 6177 | 0.070 |
Why?
|
| Sickness Impact Profile | 1 | 2008 | 138 | 0.070 |
Why?
|
| Hypertension | 1 | 2017 | 1591 | 0.070 |
Why?
|
| Twins, Dizygotic | 2 | 2000 | 48 | 0.070 |
Why?
|
| Africa | 1 | 2007 | 151 | 0.070 |
Why?
|
| Korea | 2 | 1997 | 64 | 0.070 |
Why?
|
| Stress, Psychological | 1 | 2014 | 1043 | 0.070 |
Why?
|
| Twins, Monozygotic | 2 | 2000 | 136 | 0.070 |
Why?
|
| Risk Reduction Behavior | 1 | 2007 | 208 | 0.070 |
Why?
|
| Education | 1 | 2006 | 125 | 0.060 |
Why?
|
| Feeding Behavior | 1 | 2012 | 817 | 0.060 |
Why?
|
| Follow-Up Studies | 5 | 2007 | 15218 | 0.060 |
Why?
|
| United States | 7 | 2015 | 15861 | 0.060 |
Why?
|
| Factor Analysis, Statistical | 1 | 2005 | 353 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2023 | 33737 | 0.060 |
Why?
|
| Severity of Illness Index | 4 | 2014 | 4372 | 0.060 |
Why?
|
| Czech Republic | 1 | 2003 | 18 | 0.050 |
Why?
|
| Biopsy | 4 | 1999 | 3484 | 0.050 |
Why?
|
| Water Supply | 1 | 2002 | 30 | 0.050 |
Why?
|
| Citric Acid | 2 | 2001 | 53 | 0.050 |
Why?
|
| Hygiene | 1 | 2002 | 29 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2012 | 6224 | 0.050 |
Why?
|
| Louisiana | 1 | 2002 | 148 | 0.050 |
Why?
|
| Antitrichomonal Agents | 1 | 2001 | 10 | 0.050 |
Why?
|
| Double-Blind Method | 4 | 2000 | 2580 | 0.050 |
Why?
|
| Etidronic Acid | 1 | 2000 | 11 | 0.050 |
Why?
|
| Erythema | 1 | 2001 | 48 | 0.050 |
Why?
|
| Nurse's Role | 1 | 2001 | 45 | 0.050 |
Why?
|
| Cellulitis | 1 | 2001 | 80 | 0.050 |
Why?
|
| Clarithromycin | 1 | 2001 | 126 | 0.050 |
Why?
|
| Wound Infection | 1 | 2001 | 66 | 0.040 |
Why?
|
| Calcium Channel Blockers | 1 | 2000 | 143 | 0.040 |
Why?
|
| Nuclear Family | 1 | 2000 | 68 | 0.040 |
Why?
|
| Equipment Failure | 1 | 2001 | 191 | 0.040 |
Why?
|
| Equipment Design | 2 | 2001 | 1197 | 0.040 |
Why?
|
| Comorbidity | 1 | 2007 | 2394 | 0.040 |
Why?
|
| Psychometrics | 1 | 2005 | 973 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2001 | 413 | 0.040 |
Why?
|
| Bacteriological Techniques | 1 | 2000 | 123 | 0.040 |
Why?
|
| Breast Feeding | 1 | 2001 | 246 | 0.040 |
Why?
|
| Endoscopes, Gastrointestinal | 1 | 1999 | 15 | 0.040 |
Why?
|
| Evaluation Studies as Topic | 2 | 1996 | 452 | 0.040 |
Why?
|
| Sialic Acids | 1 | 1999 | 24 | 0.040 |
Why?
|
| Disease Transmission, Infectious | 1 | 2000 | 99 | 0.040 |
Why?
|
| Atrophy | 2 | 1996 | 271 | 0.040 |
Why?
|
| Lactose | 1 | 1999 | 68 | 0.040 |
Why?
|
| Spouses | 1 | 2000 | 140 | 0.040 |
Why?
|
| Mental Disorders | 1 | 2006 | 882 | 0.040 |
Why?
|
| Esophagus | 2 | 1999 | 563 | 0.040 |
Why?
|
| Surgical Instruments | 1 | 1999 | 141 | 0.040 |
Why?
|
| Lactoferrin | 1 | 1999 | 87 | 0.040 |
Why?
|
| Fiber Optic Technology | 1 | 1999 | 146 | 0.040 |
Why?
|
| Physicians, Family | 1 | 1998 | 55 | 0.040 |
Why?
|
| Statistics, Nonparametric | 3 | 2011 | 984 | 0.040 |
Why?
|
| Duodenoscopy | 1 | 1997 | 21 | 0.040 |
Why?
|
| Health Behavior | 1 | 2002 | 601 | 0.040 |
Why?
|
| Longitudinal Studies | 2 | 2000 | 2057 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2001 | 1356 | 0.040 |
Why?
|
| Antibodies | 1 | 2000 | 809 | 0.040 |
Why?
|
| Lansoprazole | 1 | 1996 | 23 | 0.040 |
Why?
|
| 2-Pyridinylmethylsulfinylbenzimidazoles | 1 | 1996 | 28 | 0.040 |
Why?
|
| Sucrose | 1 | 1997 | 66 | 0.040 |
Why?
|
| Drug Administration Schedule | 2 | 2000 | 3530 | 0.030 |
Why?
|
| Feces | 1 | 2000 | 861 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2001 | 964 | 0.030 |
Why?
|
| Orphanages | 1 | 1996 | 6 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2010 | 8699 | 0.030 |
Why?
|
| Residence Characteristics | 1 | 1999 | 356 | 0.030 |
Why?
|
| Patient Selection | 2 | 2001 | 2025 | 0.030 |
Why?
|
| False Negative Reactions | 1 | 1996 | 291 | 0.030 |
Why?
|
| Housing | 1 | 1996 | 67 | 0.030 |
Why?
|
| Alcoholism | 1 | 1999 | 332 | 0.030 |
Why?
|
| False Positive Reactions | 1 | 1996 | 375 | 0.030 |
Why?
|
| Child, Hospitalized | 1 | 1996 | 71 | 0.030 |
Why?
|
| Gastroenterology | 1 | 1998 | 200 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2007 | 6764 | 0.030 |
Why?
|
| Adjuvants, Immunologic | 1 | 1999 | 695 | 0.030 |
Why?
|
| Virulence | 1 | 2015 | 352 | 0.030 |
Why?
|
| Aspirin | 1 | 1997 | 375 | 0.030 |
Why?
|
| Child Rearing | 1 | 1994 | 30 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 2000 | 1105 | 0.030 |
Why?
|
| Pregnancy | 1 | 2007 | 8130 | 0.030 |
Why?
|
| Topography, Medical | 1 | 2013 | 6 | 0.030 |
Why?
|
| Crowding | 1 | 2013 | 10 | 0.030 |
Why?
|
| Hepatitis C, Chronic | 1 | 1999 | 471 | 0.030 |
Why?
|
| Community-Acquired Infections | 1 | 1996 | 286 | 0.030 |
Why?
|
| Radionuclide Imaging | 1 | 2014 | 655 | 0.030 |
Why?
|
| Ranitidine | 1 | 1992 | 41 | 0.030 |
Why?
|
| Regression Analysis | 2 | 1992 | 1571 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 1999 | 5056 | 0.030 |
Why?
|
| Drinking Water | 1 | 2012 | 19 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2001 | 5101 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2000 | 4960 | 0.020 |
Why?
|
| Mesalamine | 1 | 2011 | 7 | 0.020 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 1991 | 101 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2000 | 4831 | 0.020 |
Why?
|
| Neoplasms | 1 | 1997 | 15927 | 0.020 |
Why?
|
| Failure to Thrive | 1 | 2011 | 96 | 0.020 |
Why?
|
| Campylobacter Infections | 1 | 1990 | 42 | 0.020 |
Why?
|
| Health Status Disparities | 1 | 2013 | 318 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2000 | 3844 | 0.020 |
Why?
|
| Aging | 2 | 1998 | 1534 | 0.020 |
Why?
|
| Steroids | 1 | 2011 | 372 | 0.020 |
Why?
|
| Radiography | 1 | 2013 | 1986 | 0.020 |
Why?
|
| Developing Countries | 1 | 1991 | 349 | 0.020 |
Why?
|
| Medicaid | 1 | 2011 | 306 | 0.020 |
Why?
|
| Eructation | 1 | 2007 | 2 | 0.020 |
Why?
|
| Endoscopy, Gastrointestinal | 2 | 2000 | 375 | 0.020 |
Why?
|
| Bronchial Spasm | 1 | 2007 | 8 | 0.020 |
Why?
|
| Laryngitis | 1 | 2007 | 6 | 0.020 |
Why?
|
| Proton Pumps | 1 | 2007 | 12 | 0.020 |
Why?
|
| Hoarseness | 1 | 2007 | 26 | 0.020 |
Why?
|
| Hiccup | 1 | 2007 | 17 | 0.020 |
Why?
|
| Pharyngitis | 1 | 2007 | 47 | 0.020 |
Why?
|
| Immunologic Factors | 1 | 2011 | 672 | 0.020 |
Why?
|
| Sialorrhea | 1 | 2007 | 16 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 4328 | 0.020 |
Why?
|
| Cough | 1 | 2007 | 125 | 0.020 |
Why?
|
| Chest Pain | 1 | 2007 | 173 | 0.020 |
Why?
|
| Biomarkers | 1 | 2015 | 5051 | 0.010 |
Why?
|
| Kazakhstan | 1 | 2002 | 8 | 0.010 |
Why?
|
| Hepatitis A Antibodies | 1 | 2002 | 9 | 0.010 |
Why?
|
| Carbon Radioisotopes | 1 | 2001 | 124 | 0.010 |
Why?
|
| Drug Resistance, Microbial | 1 | 2001 | 243 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 1994 | 5776 | 0.010 |
Why?
|
| Vietnam | 1 | 2000 | 65 | 0.010 |
Why?
|
| Occupations | 1 | 2000 | 54 | 0.010 |
Why?
|
| Reference Standards | 1 | 2001 | 366 | 0.010 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2000 | 130 | 0.010 |
Why?
|
| Pentagastrin | 1 | 1999 | 12 | 0.010 |
Why?
|
| Gastric Acidity Determination | 1 | 1999 | 20 | 0.010 |
Why?
|
| Temperance | 1 | 1999 | 21 | 0.010 |
Why?
|
| Glucans | 1 | 1999 | 20 | 0.010 |
Why?
|
| Citrates | 1 | 1999 | 32 | 0.010 |
Why?
|
| Substance Abuse, Intravenous | 1 | 1999 | 47 | 0.010 |
Why?
|
| Patient Compliance | 2 | 1995 | 676 | 0.010 |
Why?
|
| Hydrolysis | 1 | 1999 | 237 | 0.010 |
Why?
|
| Colonoscopes | 1 | 1999 | 24 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1999 | 143 | 0.010 |
Why?
|
| Equipment Safety | 1 | 1999 | 64 | 0.010 |
Why?
|
| Liver Function Tests | 1 | 1999 | 185 | 0.010 |
Why?
|
| Colostrum | 1 | 1999 | 58 | 0.010 |
Why?
|
| Esophagoscopy | 1 | 2000 | 310 | 0.010 |
Why?
|
| Ascorbic Acid | 1 | 1999 | 131 | 0.010 |
Why?
|
| Information Services | 1 | 1998 | 42 | 0.010 |
Why?
|
| Reference Values | 1 | 1999 | 1133 | 0.010 |
Why?
|
| Cattle | 1 | 1999 | 833 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 1999 | 425 | 0.010 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 1996 | 68 | 0.010 |
Why?
|
| Alcohol Drinking | 1 | 1999 | 600 | 0.010 |
Why?
|
| Biological Transport | 1 | 1997 | 626 | 0.010 |
Why?
|
| Acute Disease | 1 | 2000 | 2493 | 0.010 |
Why?
|
| Colonoscopy | 1 | 1999 | 522 | 0.010 |
Why?
|
| Administration, Oral | 1 | 1999 | 1608 | 0.010 |
Why?
|
| Twin Studies as Topic | 1 | 1994 | 20 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2000 | 3476 | 0.010 |
Why?
|
| Observer Variation | 1 | 1996 | 709 | 0.010 |
Why?
|
| Causality | 1 | 1994 | 176 | 0.010 |
Why?
|
| Stomach Diseases | 1 | 1994 | 72 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1999 | 3028 | 0.010 |
Why?
|
| ROC Curve | 1 | 1996 | 1248 | 0.010 |
Why?
|
| Treatment Failure | 1 | 1995 | 1430 | 0.010 |
Why?
|
| Genotype | 1 | 2000 | 4252 | 0.010 |
Why?
|
| Arkansas | 1 | 1991 | 61 | 0.010 |
Why?
|
| Neutrophils | 1 | 1996 | 873 | 0.010 |
Why?
|
| Epidemiologic Methods | 1 | 1991 | 254 | 0.010 |
Why?
|
| Saudi Arabia | 1 | 1990 | 47 | 0.010 |
Why?
|
| India | 1 | 1991 | 318 | 0.010 |
Why?
|
| Campylobacter | 1 | 1990 | 29 | 0.010 |
Why?
|
| Smoking | 1 | 1990 | 2555 | 0.000 |
Why?
|
| Animals | 1 | 1999 | 61956 | 0.000 |
Why?
|